Navigation Links
LaVoie Group Appointed by Mithridion as PR Agency

SALEM, Mass., May 4 /PRNewswire/ -- LaVoie Group, a life science-focused strategic communications agency, announced today that it has added Mithridion, Inc. to its life sciences agency client roster.

Donna L. LaVoie, President & CEO of LaVoie Group, commented, "We are delighted to be working on the leading edge of the life sciences sector. As a pioneer in the development of therapeutics for complex central nervous system disorders, Mithridion's strategy is a combination of partnerships and proprietary pipeline development. We look forward to representing them as the company moves its pipeline forward."

Trevor M. Twose, Chief Executive Officer of Mithridion, commented, "We selected LaVoie Group because of their in-depth expertise in the life sciences sector, and their creative, results-orientated ideas. LaVoie Group is a natural fit to help us become a more established brand in the CNS space."

About Mithridion, Inc.

Mithridion, Inc. is a biopharmaceutical company that discovers and develops drugs for central nervous system (CNS) disorders, with an initial focus on Alzheimer's disease and schizophrenia. Through the company's research and development efforts, as well as its merger with Cognitive Pharmaceuticals Ltd. in June 2008, Mithridion is developing a pipeline of CNS drug candidates. MCD-386, the company's lead candidate, is in a Phase I clinical trial for AD. Through Mithridion's effective clinical execution, the company was able to advance MCD-386 to initial clinical results within nine months of the merger with Cognitive Pharmaceuticals. Mithridion has raised $7.4 million of angel and venture funding to date. For more information, please visit,

About LaVoie Group, Inc.

LaVoie Group provides senior-level strategic counsel and tactical implementation of venture, investor and public relations programs designed to properly position, create visibility and drive value for each client. We help our life sciences companies attract capital, reach corporate partners, generate revenue and build their companies through integrated communications programs. Our clients range from privately held start-ups to industry leaders in life sciences such as Vertex Pharmaceuticals, ESBATech AG, and Agile Therapeutics.

In March 2009, LaVoie Group was awarded the coveted 2008 Impact Award for "Best Industry-Exclusive Agency," sponsored by the League of American Communications Professionals (LACP). LaVoie Group is ranked by O'Dwyer's PR Report as one of the leading independent healthcare PR firms in the U.S. For more information, please visit

SOURCE LaVoie Group
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. LaVoie Group Adds Cancer Therapeutics Company, Neotropix(R),to Its Life Science Agency Roster
2. LaVoie Group Adds Interleukin Genetics to its Life Science Agency Roster
3. LaVoie Group Adds Two New Companies to Its Life Science Client Roster
4. AMERIGROUP Corporation to Webcast Annual Meeting of Stockholders on May 7, 2009
5. AMERIGROUP Reports Q1 Net Income of $36.9 Million or $0.69 per Diluted Share
6. Current Health Medical Group Makes House Calls to Combat Swine Flu Epidemic
7. The Ensign Group Schedules First Quarter 2009 Earnings Call for Thursday, May 7, 2009
8. Prospero Group (PRPG) and Fincor (FINC) Made a Share Transfer and Enter the Market with ACTRx a New Malaria and Dengue Fever Treatment
9. International Coal Group Is Lead Sponsor for West Virginia Susan G. Komen Race For The Cure
10. Pandemic Flu Preparedness Guides for Families, Businesses, Medical Providers, and Community Groups Released by Trust for Americas Health
11. Top Policy Groups Take Action to Create Healthy Communities, Prevent Childhood Obesity
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, the leading ... with Tennessee Counseling Association. This new relationship allows TherapySites to continue ... Association, adding exclusive benefits and promotional offers. , "TCA is extremely excited about ...
(Date:6/26/2016)... Michigan (PRWEB) , ... June 26, 2016 , ... On ... as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle ... honor of the city’s history as home to some of the world’s leading providers ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts ... applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention ... health care topics including advance care planning, healthcare costs and patient and family ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
(Date:6/23/2016)... WAYNE, Pa. , June 23, 2016 ... provider, will launch its next generation clinical outcomes platform, Bracket ... DIA Meeting held on June 26 – 30, 2016 in ... 6.0, the first electronic Clinical Outcome Assessment product of its ... DIA Booth #715. Bracket eCOA 6.0 is a ...
Breaking Medicine Technology: